Diabetes Research Centers (P30 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications for Diabetes Research Centers that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. Diabetes Research Centers support two primary research-related activities: Research Core services and a Pilot and Feasibility (P and F) program.

DIABETES RESEARCH CENTERS

Kevan Herold Kevan Herold MD Yale University Yale University
My background and research are in translational immunology. I am interested in understanding the basis for autoimmune diseases and developing new therapies based on our understanding of disease mechanisms. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Matthew J Tyska Matthew J Tyska MD Vanderbilt University Vanderbilt University
The overarching goal of the Tyska Laboratory is to understand how transporting epithelial cells assemble a functional apical surface. Intestinal epithelial cells in particular build one of the most elaborate apical specializations, an array of microvilli known as the brush border. The Vanderbilt Diabetes Research and Training Center (DRTC), is a NIH-sponsored Diabetes Center that facilitates the discovery, application, and translation of scientific knowledge to improve the lives of people with diabetes.
Kenneth W Dunn Kenneth W Dunn PhD Indiana University Indiana University
Dr. Dunn’s research addresses the development of advanced methods of quantitative optical microscopy, particularly intravital multiphoton microscopy. The Center for Diabetes and Metabolic Diseases (CDMD) at IU School of Medicine is a world-renowned center focused on centralizing and fostering research along five fundamental themes to strengthen the diabetes research base throughout Indiana.
Hassan Chaib Hassan Chaib PhD Stanford University Stanford University
In 2011, Dr. Chaib joined the Genetics Department at Stanford University, focusing on next generation sequencing technologies and stem cell therapy of muscular dystrophy. He is currently the Director of Lab Operations for SCGPM and the GSSC and Director of Stem Cell Genomics at the CIRM CESCG. The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Barbara Gower Barbara Gower PhD University of Alabama at Birmingham University of Alabama at Birmingham
Dr. Gower research interests are related to obesity and energy metabolism, with an emphasis on insulin secretion/action and the role of the endocrine system The Diabetes Research and Training Center (DRC) focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications.
David A Antonetti PhD University of Michigan University of Michigan
Investigations into the formation and loss of the blood-brain and blood-retinal barrier in normal vascular biology, diabetes, cancer and stroke. Our long-term goal is to contribute to the development of novel treatments to prevent or reverse the debilitating loss of vision from diabetes. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
Christin Carter-Su Christin Carter-Su PhD University of Michigan University of Michigan
A major and longstanding interest of our laboratory is the delineation of the cellular and molecular mechanisms by which growth hormone (GH) regulates body growth and metabolism. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
Qizhi Tang Qizhi Tang PhD UCSF UCSF
The Tang lab focuses on translating knowledge on mechanisms of immune tolerance into novel therapeutics for treating autoimmune diabetes and preventing transplant rejection. The University of California San Francisco Diabetes Research Center (UCSF DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
Anthony W Ferrante Jr Anthony W Ferrante Jr MD PhD Columbia University Columbia University
The research in our laboratory focuses on identifying cellular and molecular mechanisms by which fat mass changes alter medically important traits, including insulin sensitivity and cardiac mass. The Columbia University Diabetes and Endocrinology Research Center provides research support for investigators pursuing research on diabetes and metabolic disorders.
Graeme Bell Graeme Bell PhD University of Chicago University of Chicago
Dr. Bell’s research focuses on the genetics of diabetes mellitus. Ongoing studies in his laboratory include the genetics of type 2 diabetes in the Mexican American population of Starr County, Texas. The University of Chicago Diabetes Research and Training Center (DRTC) provides resources for the support and coordination of the research and training activities in diabetes and related metabolic and endocrine disorders of a large and growing number of independently funded but highly interactive investigators.
Rexford S Ahima Rexford S Ahima MD PhD Johns Hopkins University - University of Maryland Johns Hopkins University - University of Maryland
Dr. Ahima is the Director of the Division of Endocrinology, Diabetes and Metabolism, Bloomberg Distinguished Professor of Diabetes in the Schools of Medicine, Public Health and Nursing, and the leader of the Johns Hopkins Diabetes Initiative. The Johns Hopkins University - University of Maryland Diabetes Research Center fosters collaborative, multidisciplinary diabetes and endocrinology research, and translates that research into programs that advance the diagnosis and management of diabetes mellitus by health care professionals.
Adolfo Garcia-Ocaña Adolfo Garcia-Ocaña PhD Albert Einstein College of Medicine Albert Einstein College of Medicine
Dr. Garcia-Ocaña’s research interest has focused over the years on tissue regeneration, growth factors and intracellular signaling. The Einstein-Mount Sinai Diabetes Research Center (ES-DRC) comprises a vibrant, extensive, diverse, well-funded and highly productive program that provides the foundation for high-quality and cutting-edge research in diabetes and related studies in obesity, metabolism and endocrinology.
Seung K Kim Seung K Kim MD PhD Stanford University Stanford University
Seung K. Kim is Professor in the Department of Developmental Biology and, by courtesy, in the Department of Medicine (Oncology Division) at Stanford University School of Medicine, where he has been a faculty member since 1998. The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Stuart J Frank Stuart J Frank MD University of Alabama at Birmingham University of Alabama at Birmingham
The focus of research in my laboratory is in understanding mechanisms of action of growth hormone (GH), an important metabolic and growth promoting hormone. The Diabetes Research and Training Center (DRC) focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications.
John W Turk John W Turk MD PhD Washington University in St Louis Washington University in St Louis
Dr. John W Turk is a Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at Washington University in St. Louis, and Director of the Mass Spectrometry Resource Core. TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
Raghavendra G Mirmira MD PhD Indiana University Indiana University
Dr. Mirmira’s research program over the past 10 years has centered upon the biology of islets as it relates to islet development/growth, maintenance, and survival. The Center for Diabetes and Metabolic Diseases (CDMD) at IU School of Medicine is a world-renowned center focused on centralizing and fostering research along five fundamental themes to strengthen the diabetes research base throughout Indiana.

Diabetes Centers Overview

Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.

In the Spotlight

Pilot & Feasibility Study
Center Publication
Columbia University Columbia Vanderbilt University Vanderbilt 
β-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells., Sui, Lina, Danzl Nichole, Campbell Sean R., Viola Ryan, Williams Damian, Xing Yuan, Wang Yong, Phillips Neil, Poffenberger Greg, Johannesson Bjarki, et al. , Diabetes, 2018 01, Volume 67, Issue 1, p.26-35, (2018)
NIDDK Center
The Centers for Diabetes Translation Research are part of an integrated program whose cores support and enhance diabetes type II translation research (e.g. bedside to practice and the community, dissemination and implementation science).
Diabetes Resource
This NHLBI study is testing whether strict glucose control lowers the risk of heart disease and stroke in adults with type 2 diabetes.